These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 1934689
1. von Willebrand factor in synovial fluid. Bolosiu HD, Rus V, Parasca I, Dutu A, Malide D. Clin Exp Rheumatol; 1991; 9(4):395-8. PubMed ID: 1934689 [Abstract] [Full Text] [Related]
2. von Willebrand factor in the plasma of patients with rheumatic diseases. Duţu A, Rus V, Boloşiu HD, Parasca I, Cristea A, Malide D. Med Interne; 1989; 27(4):273-8. PubMed ID: 2617082 [Abstract] [Full Text] [Related]
3. Serum and synovial fluid osteocalcin in rheumatic diseases. Mattei JP, Ferrera V, Boutsen Y, Franceschi JP, Botti D, De Boissezon C, Kaphan G, Roux H. Int J Clin Pharmacol Res; 1992; 12(3):103-7. PubMed ID: 1473875 [Abstract] [Full Text] [Related]
4. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Reiter RA, Varadi K, Turecek PL, Jilma B, Knöbl P. Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809 [Abstract] [Full Text] [Related]
5. Local and systemic inflammatory lipid profiling in a rat model of osteoarthritis with metabolic dysregulation. de Visser HM, Mastbergen SC, Ravipati S, Welsing PMJ, Pinto FC, Lafeber FPJG, Chapman V, Barrett DA, Weinans H. PLoS One; 2018 Mar; 13(4):e0196308. PubMed ID: 29684084 [Abstract] [Full Text] [Related]
6. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. Arthritis Res Ther; 2005 Mar; 7(4):R817-24. PubMed ID: 15987483 [Abstract] [Full Text] [Related]
7. Elevated plasma von Willebrand factor levels in patients with active ulcerative colitis reflect endothelial perturbation due to systemic inflammation. Zezos P, Papaioannou G, Nikolaidis N, Vasiliadis T, Giouleme O, Evgenidis N. World J Gastroenterol; 2005 Dec 28; 11(48):7639-45. PubMed ID: 16437691 [Abstract] [Full Text] [Related]
8. Differential levels of synovial fluid aggrecan aggregate components in experimental osteoarthritis and joint disuse. Ratcliffe A, Beauvais PJ, Saed-Nejad F. J Orthop Res; 1994 Jul 28; 12(4):464-73. PubMed ID: 7520485 [Abstract] [Full Text] [Related]
12. Aberrant vascularity and von Willebrand factor distribution in inflamed synovial membrane. Ceponis A, Konttinen YT, MacKevicius Z, Solovieva SA, Hukkanen M, Tamulaitiene M, Matulis A, Santavirta S. J Rheumatol; 1996 Nov 28; 23(11):1880-6. PubMed ID: 8923360 [Abstract] [Full Text] [Related]
20. Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation. Chockalingam PS, Glasson SS, Lohmander LS. Osteoarthritis Cartilage; 2013 Feb 28; 21(2):339-45. PubMed ID: 23142724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]